CUE – cue biopharma, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

CUE

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

2/17

08:00 am

cue

Cue Biopharma Announces Preclinical Safety and Tolerability Data for CUE-401 for the Treatment of Autoimmune and Inflammatory Diseases

Low Report

Cue Biopharma Announces Preclinical Safety and Tolerability Data for CUE-401 for the Treatment of Autoimmune and Inflammatory Diseases

Report

2/12

08:00 am

cue

Cue Biopharma Appoints Industry Veteran Lucinda Warren as Chief Financial and Business Officer

Medium Report

Cue Biopharma Appoints Industry Veteran Lucinda Warren as Chief Financial and Business Officer

Report

12/19

08:35 am

cue

Cue Biopharma Announces Pricing of $10 Million Public Offering [Yahoo! Finance]

Low Report

Cue Biopharma Announces Pricing of $10 Million Public Offering [Yahoo! Finance]

Report

12/19

08:00 am

cue

Cue Biopharma Announces Pricing of $10 Million Public Offering

Low Report

Cue Biopharma Announces Pricing of $10 Million Public Offering

Report

12/18

04:02 pm

cue

Cue Biopharma Announces Proposed Public Offering

Medium Report

Cue Biopharma Announces Proposed Public Offering

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.